Resource Center
This section contains international research and may reference indications not approved in all regions. Please consult local approved indications before use.
Filter By:
- News
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
- News
Innovation happens when clinicians and technology come together.
- News
Stop by the GE HealthCare booth to experience Pulsenmore
- News, Press releases
Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next
- News, Press releases
RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health
- News, Press releases
A new handheld, self-scanning ultrasound device that attaches to a smartphone allows pregnant women to see their baby in the womb at any time and in the comfort of their
the news pulse
We invite you to keep up to date with the latest updates by registering to our quarterly newsletter
FAQ